The possible of immunotherapy for COVID-19: A systematic review
A AminJafari, S Ghasemi - International immunopharmacology, 2020 - Elsevier
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …
described in late December 2019 and causes a severe respiratory infection in humans …
The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19
AH Mansourabadi, M Sadeghalvad… - Life sciences, 2020 - Elsevier
Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …
Potential therapeutic options for COVID-19: an update on current evidence
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …
pandemic and is a major public health concern nowadays. The rapid and global spread of …
[HTML][HTML] Perspectives of immune therapy in coronavirus disease 2019
AY Gasparyan, DP Misra… - Journal of Korean …, 2020 - synapse.koreamed.org
The global fight against coronavirus disease 2019 (COVID-19) is largely based on strategies
to boost immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
to boost immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
[HTML][HTML] Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …
[HTML][HTML] Immune response in COVID-19: A review
The immune system protects us from viruses and diseases. It produces an antibody to kill
pathogen. This review shows a brief picture about the immune system to protect us from …
pathogen. This review shows a brief picture about the immune system to protect us from …
SARS-CoV-2: immune response elicited by infection and development of vaccines and treatments
G Canedo-Marroquin, F Saavedra… - Frontiers in …, 2020 - frontiersin.org
The World Health Organization (WHO) announced in March a pandemic caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was …
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was …
Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view
A Kronbichler, M Effenberger, M Eisenhut, KH Lee… - Autoimmunity …, 2020 - Elsevier
Now COVID-19 is causing a severe public health emergency and the mortality is rapidly
increasing all over the world. In the current pandemic era, although there have been many …
increasing all over the world. In the current pandemic era, although there have been many …
COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
Immunotherapeutic approaches to curtail COVID-19
COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug …
coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug …